EP0318851A3 - Neue Labdanderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel - Google Patents
Neue Labdanderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Download PDFInfo
- Publication number
- EP0318851A3 EP0318851A3 EP88119643A EP88119643A EP0318851A3 EP 0318851 A3 EP0318851 A3 EP 0318851A3 EP 88119643 A EP88119643 A EP 88119643A EP 88119643 A EP88119643 A EP 88119643A EP 0318851 A3 EP0318851 A3 EP 0318851A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- preparation
- medicines
- derivatives
- labdane derivatives
- labdane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 150000001761 labdane diterpenoid derivatives Chemical class 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 230000004410 intraocular pressure Effects 0.000 abstract 1
- 230000001057 ionotropic effect Effects 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3740625 | 1987-12-01 | ||
DE19873740625 DE3740625A1 (de) | 1987-12-01 | 1987-12-01 | Neue labdanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0318851A2 EP0318851A2 (de) | 1989-06-07 |
EP0318851A3 true EP0318851A3 (de) | 1990-08-08 |
Family
ID=6341610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP88119643A Withdrawn EP0318851A3 (de) | 1987-12-01 | 1988-11-25 | Neue Labdanderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0318851A3 (da) |
JP (1) | JPH01186877A (da) |
KR (1) | KR890009917A (da) |
AU (1) | AU628794B2 (da) |
DE (1) | DE3740625A1 (da) |
DK (1) | DK668788A (da) |
HU (1) | HU203092B (da) |
PT (1) | PT89103B (da) |
ZA (1) | ZA888937B (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ223051A (en) * | 1986-12-29 | 1990-06-26 | Hoechst Roussel Pharma | Carbamoyloxylabdane derivatives and pharmaceutical compositions |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0116713A1 (en) * | 1982-12-27 | 1984-08-29 | Schering Corporation | Novel labdane derivatives, process for the preparation thereof, and pharmaceutical compositions containing labdane derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4782082A (en) * | 1982-12-27 | 1988-11-01 | Schering Corporation | Method for treating allergic reactions with Forskolin |
-
1987
- 1987-12-01 DE DE19873740625 patent/DE3740625A1/de not_active Withdrawn
-
1988
- 1988-11-25 EP EP88119643A patent/EP0318851A3/de not_active Withdrawn
- 1988-11-29 PT PT89103A patent/PT89103B/pt not_active IP Right Cessation
- 1988-11-29 ZA ZA888937A patent/ZA888937B/xx unknown
- 1988-11-30 KR KR1019880015813A patent/KR890009917A/ko not_active Application Discontinuation
- 1988-11-30 JP JP63301119A patent/JPH01186877A/ja active Pending
- 1988-11-30 DK DK668788A patent/DK668788A/da not_active Application Discontinuation
- 1988-11-30 AU AU26368/88A patent/AU628794B2/en not_active Ceased
- 1988-12-01 HU HU886136A patent/HU203092B/hu not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0116713A1 (en) * | 1982-12-27 | 1984-08-29 | Schering Corporation | Novel labdane derivatives, process for the preparation thereof, and pharmaceutical compositions containing labdane derivatives |
Non-Patent Citations (1)
Title |
---|
TETRAHEDRON LETTERS, Nr. 19, Mai 1977, Seiten 1669-1672, Pergamon Press, Oxford, GB; S.V. BHAT et al.: "Structures and stereochemistry of new labdane diterpenoids from coleus forskohlii briq" * |
Also Published As
Publication number | Publication date |
---|---|
ZA888937B (en) | 1989-07-26 |
HU203092B (en) | 1991-05-28 |
PT89103B (pt) | 1993-03-31 |
JPH01186877A (ja) | 1989-07-26 |
KR890009917A (ko) | 1989-08-04 |
PT89103A (pt) | 1988-12-01 |
DE3740625A1 (de) | 1989-06-15 |
AU628794B2 (en) | 1992-09-24 |
DK668788D0 (da) | 1988-11-30 |
DK668788A (da) | 1989-06-02 |
AU2636888A (en) | 1989-06-01 |
HUT50807A (en) | 1990-03-28 |
EP0318851A2 (de) | 1989-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69025920D1 (de) | Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten | |
EP1095656A3 (de) | Pharmazeutische Zubereitung mit dem Cholinesterase-Hemmstoff Galanthamin | |
ATA312987A (de) | Brenzkatechin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe | |
AT388551B (de) | 1-hydroxy-2-pyridone, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten, sowie bei der herstellung der 1-hydroxy-2-pyridone gebildete zwischenprodukte | |
DE3879873D1 (de) | Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE68909412D1 (de) | Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen. | |
ATA69888A (de) | Neue substituierte benzamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese benzamide enthalten | |
EP0252482A3 (de) | 7-Acyloxy-6-aminoacyloxypolyoxylabdane, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
EP0206076A3 (de) | 1,8-Verbrückte 4-Chinolon-3-carbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel und ihre Verwendung zur Herstellung von Arzneimitteln | |
ATE58538T1 (de) | 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
EP0318851A3 (de) | Neue Labdanderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
EP0315097A3 (de) | Neue Acyllabdan-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
EP0402923A3 (de) | Neue 2,5-Diaminotetraline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
DE3770726D1 (de) | Decahydrochinolinderivate, verfahren zu ihrer herstellung und zwischenprodukte davon, ihre verwendung als arzneimittel und ihre pharmazeutischen zusammensetzungen. | |
ATE121396T1 (de) | Dibenzo(1,5)dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung. | |
EP0318855A3 (de) | Neue Labdan-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
EP0163984A3 (de) | Dihydropyridinkombinationspräparate und Verfahren zu ihrer Herstellung | |
ATA67488A (de) | Immunglobulinkonjugate, verfahren zu deren herstellung und anwendung sowie pharmazeutische mittel, die diese enthalten | |
EP0225552A3 (de) | Enantiomerenreine 1,8-verbrückte 4-chinolon-3-carbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel und ihre Verwendung zur Herstellung von Arzneimitteln | |
DE69623491D1 (de) | Neue säurederivate des pyrazols, verfahren zu ihrer herstellung, ihre anwendung als medikamente, ihre neue anwendung und die sie enthaltende pharmazeutische zusammensetzungen | |
EP0273199A3 (de) | Arzneimittel auf Basis von Derivaten des 3,4-Diphenylpiperidins, die Verwendung der Derivate als Arzneimittel sowie neue 3,4-Diphenylpiperidinderivate und Verfahren zu ihrer Herstellung | |
EP0149818A3 (de) | Neue 1,4-Naphthochinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
DE3774359D1 (de) | 3-(1h-tetrazol-5-yl)oxanilsaeure, salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
ATE7911T1 (de) | Pharmazeutisch zulassbare salze von 4'-(9acridinylamino)methansulfon-m-anisid, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3785987D1 (de) | Imidazol-derivate und deren salze, verfahren zu deren herstellung, deren anwendung als arzneimittel und deren zusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
17P | Request for examination filed |
Effective date: 19901221 |
|
17Q | First examination report despatched |
Effective date: 19930504 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 19940311 |